b'Special InitiativesSuccess storiestor. I want to congratulate the leadership group at AAFC who shared our vision to support a team Canada approach to sciencebreaking down organisational silos so that the best Canadian scientists can come together to address important problems whether they are in government labs, in academia or in industry.We continue to work productively with our Genome Cen- tres across Canada, reinforcing a distributed model that com-bines national breadth with regional depth. Our new Regional PrioritiesPartnershipProgramisdesignedtoprioritize provincial or regional opportunities that support the national mission. We also aligned our communications and outreach activities more closely, including through a National Dialogue Series on Genomics that saw public outreach events occur across Canada.This year also saw the launch of a major national initia-tive in the precision health of rare disease. Bringing together clinicians and researchers from across Canada, this Genome Canada-led initiative aims to make genomics-based preci-sion health available to every rare disease patient in Canada within three years. Working with provincial governments,Prioritizing pediatric hospitals, clinicians, researchers and patients, this initiative is tackling barriers to implementation while open- Mental Health ing opportunities for improved diagnosis and care.This was also an important year for internal matters atResearchGenome Canada. We engaged our community in the develop-ment of a new Strategic Vision, conducting consultations and meetings throughout the year, identifying new opportunitiesBipolar disorder is a chronic psychiatric for the next phase of Genome Canadas growth. We also con- illness that affects an estimated 500,000 ducted a significant review of our integrated GE 3 LS 1program,Canadians and is one of the top causes recommitting to this innovative interdisciplinary approach toof disability and mortality worldwide. genomic research. And finally, we developed and launchedGenetic factors influence who is at an Equity, Diversity and Inclusion (EDI) action plancommit- risk and how individuals respond to ting to increasing representation across underrepresentedtreatment. Mental health researchers groups at Genome Canada.Drs. Martin Alda and Rudolf Uher from Clearly, there is a lot happening at Genome Canada. As weDalhousie University are examining the head toward our 20 thanniversary next year there is a naturalgenetic factors that play a role in the tendency to look back at our successes and appreciate thedisorder in order to develop new clinical good work that has been done. But what motivates usandtools and improve diagnosis. By taking a what is demonstrated hereis the belief that the best is yetgenomics-based approach, this research to come. will help streamline diagnosis and identify long-term treatment for patients at the individual level. This project is supported under the Regional Priorities Partnership Marc LePage Program (RP3), which aims to advance the President and chief executive officerunique economic opportunities and sector priorities among Canadas regions.1GE 3 LS = Genomics and its Ethical, Environmental, Economic, Legal and Social aspectsGenome Canada Annual Report 2018-19 3'